CHMA Articles, Chiasma Inc.
home / stock / chma / chma articles
No one has written and article on Chiasma Inc., stock symbol CHMA. Be the first to contribute and write an article.
News, Short Squeeze, Breakout and More Instantly...
-
Pulmatrix appoints Director Anand Varadan PR Newswire LEXINGTON, Mass. , July 27, 2021 /PRNewswire/ -- Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and...
-
NEEDHAM, Mass., June 28, 2021 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), (“Chiasma” or the “Company”), a commercial-stage biopharmaceutical company utilizing its delivery platform technology to develop and commercialize oral therapies to improve the lives ...
-
NEEDHAM, Mass., May 27, 2021 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), (“Chiasma” or the “Company”) today presented patient-reported outcomes (PROs) data from its MPOWERED™ Phase 3 trial demonstrating that study patients with acromegaly reported si...
User Article Content Posts are Active
Member Article Content Creation is Now Live!
The member article and content must reference a US or Canadian Stock Symbol. You can search for a stock symbol for reference.
Menu Example
Login or Sign Up and proceed to the create article section